CA184043_4: CA184043, figure 4

CA184043_4R Documentation

CA184043, figure 4

Description

Kaplan-Meier digitized data from CA184043, figure 4 (PMID 24831977). A reported sample size of 799 for a primary endpoint of OS in prostate cancer.

Usage

CA184043_4

Format

A data frame of 799 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (ipilimumab, placebo)

Source

Kwon ED, Drake CG, Scher HI, et al. Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol 2014; 15: 700–12.

Examples

summary(CA184043_4)

kmplot(CA184043_4)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.